{"id":"W4389869854","doi":"10.1002/jcph.2397","title":"Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103)","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Pharmacokinetics; TIGIT; Dosing; Medicine; Pharmacology; Chemistry; Internal medicine; Cancer; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001144317,0.0007844873,0.001645964,0.0002887699,0.0003064364,0.001021998,0.0003319046,0.0006856001,0.001165347],"category_scores_gemma":[0.001019428,0.0004514688,0.001201861,0.0003216879,0.0003674098,0.0004831732,0.00023746,0.001959174,0.0005961563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001074482,"about_ca_system_score_gemma":0.0009180912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007737936,"about_ca_topic_score_gemma":0.001030865,"domain_scores_codex":[0.9995775,0.0001762545,0.00002217628,0.00007860451,0.0000590694,0.00008643759],"domain_scores_gemma":[0.9995547,0.00009246378,0.0001255995,0.00004502613,0.00003626318,0.0001459268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3361274,0.02378601,0.07708941,0.001030104,0.003630928,0.001583691,0.0007976773,0.005211606,0.3237053,0.0004700167,0.01040157,0.2161663],"study_design_scores_gemma":[0.06024254,0.6442331,0.2080429,0.0001205575,0.00254509,0.005069212,0.0002223315,0.01072142,0.04856885,0.0003785811,0.01970131,0.0001540326],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942908,0.002644053,0.0007294723,0.0001622603,0.00002907337,0.0002914806,0.0007325335,0.0001482621,0.0009720266],"genre_scores_gemma":[0.99657,0.0005305989,0.0007038929,0.0002866553,0.00002961047,0.0002431362,0.001037884,0.00002336625,0.0005748465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001645964,"threshold_uncertainty_score":0.00779593,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09254291781798765,"score_gpt":0.4808868178622886,"score_spread":0.388343900044301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}